Search clinical trials for: Drug interaction, SB-497115 (eltrombopag), Kaletra (Lopinavir, Ritonavir),thrombocytopenia, pharmaco
Total 264081 results
-
Case Comprehensive Cancer CenterActive, not recruitingAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedAcute Myelogenous Leukemia (AML)United States
-
Novartis PharmaceuticalsCompletedThrombocytopaeniaBelgium, Greece, Netherlands, Romania, China, Korea, Republic of, Tunisia, France, Hong Kong, Ireland, Peru, Poland
-
Weill Medical College of Cornell UniversityNovartisCompletedImmune Thrombocytopenia | Platelet DisorderUnited States
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopenic, Idiopathic | Idiopathic Thrombocytopenic PurpuraJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic Cell Transplantation Recipient | Bone Marrow Transplantation Recipient | Cord Blood Transplant RecipientUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineTerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Thrombocytopenia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
GlaxoSmithKlineCompletedChronic Idiopathic Thrombocytopenic Purpura | Purpura, Thrombocytopenic, IdiopathicJapan
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopaenic, IdiopathicUnited Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
-
GlaxoSmithKlineCompletedThrombocytopaeniaUnited States
-
GlaxoSmithKlineCompletedHepatitis CUnited States
-
GlaxoSmithKlineCompletedHepatitis C, ChronicJapan
-
Dana-Farber Cancer InstituteCompletedMultiple MyelomaUnited States
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Bulgaria, Italy, Peru, Russian Federation, Canada, France, Germany, Hong Kong, Spain, Sweden, United Kingdom, Hungary, Poland, Ukraine, Czech Republic, India, Australia, Tunisia, Puerto Rico, Pakistan
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
GlaxoSmithKlineCompletedThrombocytopaeniaSpain, Taiwan, Bulgaria, United States, Argentina, Russian Federation, Germany, Korea, Republic of, Austria, India, Italy, United Kingdom, Poland, Romania, Ukraine, Hungary, Peru, Czech Republic, Mexico
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicThailand, Korea, Republic of, United Kingdom, New Zealand, Germany, Greece, Hong Kong, Pakistan, Poland, Romania, Russian Federation, Slovenia, Taiwan
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States
-
Ingrid Pabinger, MDGlaxoSmithKlineCompletedIdiopathic Thrombocytopenic Purpura
-
Shandong Provincial HospitalUnknownAllogeneic Hematopoietic Stem Cell Transplantation | EltrombopagChina
-
General and Teaching Hospital CeljeUnknown
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopenic, IdiopathicRussian Federation
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IVGeorgia, India, Romania, Spain, Germany, Japan
-
Samsung Bioepis Co., Ltd.Organon and CoCompletedPlaque PsoriasisCzechia, Lithuania, Poland, Bulgaria
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIKorea, Republic of, Poland, Spain, Turkey
-
GlaxoSmithKlineWithdrawn
-
GlaxoSmithKlineCompleted
-
University of MinnesotaRecruitingCardiovascular Diseases | Type 2 DiabetesUnited States
-
Sangamo TherapeuticsActive, not recruitingHemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis IIUnited States
-
Nguyen Thi Trieu, MDCompletedCirrhosis of the LiverVietnam
-
SINA Health Education and Welfare TrustCompletedPolycystic Ovary Syndrome | Weight Gain | HbA1cPakistan
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedImmune Thrombocytopenic Purpura (ITP)Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
-
Samsung Bioepis Co., Ltd.CompletedPsoriasis | Moderate to Severe Plaque PsoriasisCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
-
Institute of Hematology & Blood Diseases HospitalHenan Cancer Hospital; Tianjin Medical University Cancer Institute and Hospital and other collaboratorsRecruitingEltrombopag | Chemotherapy-induced ThrombocytopeniaChina
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopaenic, Idiopathic
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicGermany, Russian Federation
-
Samsung Bioepis Co., Ltd.CompletedNeovascular Age-related Macular DegenerationCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Poland, United States, Croatia, Japan, Russian Federation
-
Samsung Bioepis Co., Ltd.CompletedMacular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular DegenerationPoland
-
Samsung Bioepis Co., Ltd.CompletedPostmenopausal OsteoporosisPoland
-
GlaxoSmithKlineCompletedSolid Tumor CancerUnited States
-
GlaxoSmithKlineCompletedLymphoma | Solid Tumor CancerUnited States
-
Groupe Francophone des MyelodysplasiesGlaxoSmithKline; NovartisCompleted
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Taiwan, Italy, Poland, Peru, Canada, Denmark, Germany, Slovakia, Spain, United Kingdom, New Zealand, China, Greece, Hong Kong, Russian Federation, Austria, Netherlands, Czech Republic, France, India, Ukraine, Tunisia, F... and more
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicItaly, Germany, Hong Kong, Korea, Republic of, United States, Pakistan, Russian Federation, India, Czech Republic, Hungary, France
-
University Hospital, LilleRecruitingLeukemia | Graft FailureFrance
-
Novartis PharmaceuticalsTerminatedPoor Graft FunctionSpain